Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03763110
Other study ID # Regenerative endodontic
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 15, 2016
Est. completion date April 15, 2019

Study information

Verified date August 2018
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to compare regenerative endodontics for necrotic young permanent anterior teeth using oral photo-activated disinfection versus triple antibiotic paste in terms of:

1. Clinical success in terms of absence of any complication such as spontaneous pain, sinus or swelling.

2. Radiographic success in terms of healing of periapical radiolucency or increase root thickness, length or apical closure.


Description:

Disinfection of the root canal system is thought to be critical to the success of Regenerative Endodontic Procedures (REPs) as infection prevents regeneration, repair and stem cell activity . A suitable material for using as intra-canal medicament seems to be antibiotic. Triple antibiotic paste (TAP) containing metronidazole, ciprofloxacin and minocycline has been reported to be a successful regimen in controlling the root canal pathogen and in managing necrotic young permanent tooth .

Recently, new disinfection methods have been developed to overcome the limitations of conventional disinfecting protocols that they may neither reduce the number of bacteria to a satisfactory level nor minimize the toxicity to periapical stem/progenitors . Other concerns regarding the use of TAP are tooth discoloration after treatment and bacterial resistance. Photo-activated oral disinfection is a novel disinfection method which present a great solution for the problem associated with triple antibiotic paste


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 40
Est. completion date April 15, 2019
Est. primary completion date December 15, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years to 13 Years
Eligibility Inclusion Criteria:

- Healthy children with no physical, mental or systemic conditions.

- Developmental age of the child is the most important factor so periapical x- ray will be taken first to assure apex immaturity.

- No sex predilection.

- Restorable necrotic young permanent anterior teeth

Exclusion Criteria:

- Root fracture.

- Internal or external root resorption.

- Parents or guardians refuse to participate in the study.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Photo Activated Disinfection
Photoactivated disinfection (PAD) is based on the interaction of a photosensitive antibacterial agent and a light source. It uses a nontoxic dye [named photosensitizer PS] and low-intensity visible light. In oxygen presentation, these combine to produce some cytotoxic species. The PS molecules attach to bacteria membrane
Drug:
antibiotic paste
An antibiotic mixture composed of cipro?oxacin, metronidazole, and minocycline, known as triple antibiotic paste (TAP) or "3mix", has been the most widely used medicament, This goes back to the studies by Hoshino et al.1996

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Outcome

Type Measure Description Time frame Safety issue
Primary absence of postoperative pain binary question by asking patients (yes or no) immediate post operative
Primary absence of postoperative pain binary question by asking patients (yes or no) at 3 months follow up
Primary absence of postoperative pain binary question by asking patients (yes or no) at 6 months follow up
Primary absence of postoperative pain binary question by asking patients (yes or no) at 9 months follow up
Primary absence of postoperative pain binary question by asking patients (yes or no) at 12 months follow up
Secondary healing of sinus Clinical success in term of absence of sinus (Yes or No) immediate post operative, 3 months, 6 months, 9 months, 12 months
Secondary healing of swelling Clinical success in term of absence of swelling (Yes or No) immediate post operative, 3 months, 6 months, 9 months, 12 months
Secondary healing of periapical radiolucency Radiographic success in term of healing of periapical or radiolucency (Yes or No) baseline, 6 months, 12 months
Secondary change in root length Radiographic evaluation by calibration of root length in millimetre by Digora baseline, 6 months, 12 months
Secondary change in dentin root thickness Radiographic evaluation by calibration of root thickness in millimetre by Digora baseline, 6 months, 12 months
Secondary change in apical diameter Radiographic evaluation by calibration of apical diameter in millimetre by Digora baseline, 6 months, 12 months
See also
  Status Clinical Trial Phase
Completed NCT01976065 - Regeneration of Pulp-Dentin Development in Teeth With Necrotic Pulps and Immature Roots Phase 1
Completed NCT00881907 - Tissue Characterization in Teeth Treated With a Regeneration Protocol Phase 0
Recruiting NCT04313010 - Effectiveness of Regenerative Endodontics Therapy for Single-rooted Mature Permanent Tooth With Pulp Necrosis N/A
Not yet recruiting NCT03813433 - Discoloration of Endosequence and Mineral Trioxde Aggregate in Revascularization of Necrotic Immature Permanent Teeth N/A
Completed NCT03589560 - Evaluation of Biodentine and Mineral Trioxide Aggregate in Revascularization of Non Vital Immature Anterior Teeth N/A
Not yet recruiting NCT03717337 - Success Rate of Single Versus Two Visit Regenerative Treatment Protocol in Non Vital Mature Anterior Teeth N/A
Completed NCT01817413 - Comparison of Two Dental Techniques Used to Treat Teeth Which Have Become Infected or Painful Following Trauma Phase 4
Completed NCT03849222 - Evaluation the Effect of Using of Apical Matrix With Apexification Procedure on Apical Healing of Necrotic Immature Teeth Phase 2/Phase 3
Completed NCT00881491 - Treatment Outcome With a Revascularization Protocol Using the Triple Versus Double Antibiotic Paste Phase 0